Ret Proto-Oncogene Protein (RET) (AA 29-273) (His tag)

Catalog No. ABIN7422907

This Recombinant Ret Proto-Oncogene protein is produced in Escherichia coli (E. coli).

Quick Overview for Ret Proto-Oncogene Protein (RET) (AA 29-273) (His tag) (ABIN7422907)

Target: Ret Proto-Oncogene (RET)

Protein Type: Recombinant

Origin: Mouse

Source: Escherichia coli (E. coli)

Application: Western Blotting (WB), SDS-PAGE (SDS), Immunogen (Imm), Positive Control (PC)

Purity: > 90 %

Product Details

Protein Characteristics: AA 29-273

Purification tag / Conjugate: This Ret Proto-Oncogene protein is labelled with His tag.

Sequence: Leu29-Phe273

Characteristics: Recombinant Ret Proto-Oncogene (RET), Prokaryotic expression, Leu29-Phe273, N-terminal His Tag

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Comment:

Isoelectric Point:5.4

Restrictions: For Research Use only

Handling

Format: Lyophilized

Buffer: PBS, pH 7.4, containing 0.01 % SKL, 1 mM DTT, 5 % Trehalose and Proclin300.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-80 °C

Storage Comment: Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Expiry Date: 12 months

Target Details

Target: Ret Proto-Oncogene (RET)

Alternative Name: Ret Proto-Oncogene

Background: CDHR16, CRet, PTC, CDHF12, HSCR1, MEN2A, MEN2B, MTC1, RET-ELE1, RET51, C-Ret, Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1, Cadherin-Related 16

Molecular Weight: 32kDa

UniProt: P35546

Pathways: RTK Signaling, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation